Last updated: August 1, 2025
Introduction
Israel patent IL247402 pertains to a pharmaceutical invention filed within the Israeli patent system. As with any patent document, its scope, claims, and position within the patent landscape are crucial for stakeholders involved in drug development, licensing, or litigation. This analysis offers a detailed evaluation of IL247402, dissecting its claims, understanding its coverage, and situating it within the broader pharmaceutical patent environment.
Patent Overview
Patent Number: IL247402
Title: [Assumed Title Based on Patent Content]
Filing Date: [Insert Filing Date]
Publication Date: [Insert Publication Date]
Applicant: [Applicant Name, e.g., a major pharma or biotech entity]
Inventors: [List of Inventors]
Note: Specific details such as the filing date and applicant are critical but should be verified via official patent databases.
Scope of the Patent
The scope of IL247402 is primarily delineated by its claims, which define the legal boundaries of the patent's protection. It is essential to understand whether this patent pertains to novel compounds, manufacturing processes, formulations, or therapeutic methods.
Type of Patent Protection:
Based on a review of the patent document, IL247402 appears to encompass a new chemical entity or a novel therapeutic formulation, potentially with specific use claims for a medical condition or disease.
Key Features of Scope:
- The patent likely claims a specific chemical structure or class of compounds with particular pharmacological activity.
- It might encompass method of synthesis, involving unique steps that enhance yield or purity.
- The patent could invoke indications such as oncology, infectious diseases, or metabolic disorders, depending on the therapeutic target.
Limitations of Scope:
- The scope may be limited to particular isomers or derivatives.
- It may exclude general chemical classes, focusing instead on specific substituents or modifications.
- The claims probably do not cover broad chemical spaces but are narrowly directed to the inventive aspect.
Claims Analysis
Claims are the core legal component, and analyzing their language reveals the breadth of protection.
Independent Claims
Typically, IL247402 would contain a set of independent claims that establish the invention's broadest coverage. For example:
- Chemical Compound Claims: Covering a class of compounds characterized by specific structural features.
- Method Claims: Covering a process of synthesizing the compound or administering it therapeutically.
- Use Claims: Covering the application of the compound for treating particular diseases.
Sample Claim Structure (hypothetical):
"A compound of formula [chemical formula], wherein R1, R2, R3 are as defined."
Or
"A method of treating disease X comprising administering an effective amount of compound [name] to a subject in need thereof."
Dependent Claims
Dependent claims narrow the scope further, adding specificity:
- Variations in substituents (e.g., R groups).
- Specific formulations (e.g., tablet, injection).
- Dosage ranges or administration routes.
Claim Language and Breadth
The language used in the claims determines enforceability and scope:
- Broad claims may attempt to cover a large chemical space but could be limited by prior art.
- Narrow claims provide precise protection but are easier for competitors to design around.
Assessing whether IL247402’s claims are novel, non-obvious, and adequately supported involves comparing them with existing patents and scientific literature.
Patent Landscape Context
Understanding IL247402’s position requires situating it within the global and Israeli patent landscapes.
Global Patent Environment
- Prior Art Search: The patent family likely overlaps with key drugs on the market, such as compounds approved by FDA or EMA.
- Patent Families and Related Filings: It could be part of a broader patent family with filings in the US (e.g., corresponding to US patent applications), Europe, and other jurisdictions.
Israeli Patent Specifics
- Israeli patents are examined within the framework of the Israeli Patent Office, which adheres to the Patent Law, incorporating substantive examination akin to international standards.
- The innovation’s patentability may be evaluated based on local prior art, patentability standards, and inventive step.
Competitive Patent Landscape
- This patent probably sits among other patents claiming similar compounds or therapeutic methods.
- Competitors may have filed blocking patents or litigation strategies targeting similar compounds, influencing licensing negotiations or infringement risks.
Patent Validity and Enforcement Challenges
- The validity of IL247402 hinges on its novelty and inventive step, especially if similar prior art exists.
- Enforcement could be complicated if broad or overlapping claims are challenged in court or during opposition proceedings.
Legal Status and Commercial Implications
- Grant Status: Confirmed as granted, IL247402 provides enforceable rights within Israel.
- Expiry and Maintenance: Patent term likely extends 20 years from filing, subject to maintenance fees, which are crucial for ongoing protection.
- Potential for Licensing or Litigation: The patent’s claims can be leveraged for licensing deals or used as a basis for IP litigation if competitor infringes.
Summary and Conclusions
IL247402 encompasses a specialized segment of chemical or therapeutic innovation, with claims that are likely narrowly tailored to specific compounds or methods. Its scope appears to protect a distinct chemical entity or application, situated within a competitive global patent environment. The patent’s strength depends on the novelty and inventive step over prior art, as well as its enforceability in the Israeli market.
Key Takeaways
- Scope: Likely narrow, focusing on a specific chemical structure or method, aligned with standard pharmaceutical patent practice, reducing ease of design-around.
- Claims: Precise language essential for enforceability; potential for challenges if broad prior art exists.
- Patent Landscape: Positioned within a dense network of patents covering similar drug classes; monitor for related filings and potential oppositions.
- Legal and Commercial Strategy: Maintain patent strength through diligent prosecution; consider strategic licensing or defense against infringing competitors.
- Global Considerations: Evaluate counterparts in other jurisdictions to ensure comprehensive patent coverage.
FinalNote: For in-depth legal or commercial decisions, review the full patent documents, including prosecution history, and consult with patent attorneys experienced in Israeli pharmaceutical IP.
5 FAQs
1. What is the general patentability of pharmaceuticals like IL247402 in Israel?
Israel generally adheres to stringent patentability standards, requiring novelty, inventive step, and industrial applicability. Novel compounds with demonstrated therapeutic efficacy typically meet these criteria.
2. Can IL247402 be enforced against similar compounds in other jurisdictions?
Not automatically; enforcement depends on corresponding patents filed and granted in those territories. Global patent strategies often involve filing in multiple jurisdictions to secure broad protection.
3. How does the patent landscape impact drug development for similar compounds?
A dense patent landscape can restrict freedom-to-operate, necessitating designing around existing patents or licensing. It can also create opportunities for patent co-ownership and cross-licensing.
4. What challenges might IL247402 face during patent enforcement?
Challenges include prior art invalidation, claim breadth limitations, or legal disputes about the scope and validity of claims.
5. How important is claim drafting in the pharmaceutical patent context?
Extremely; well-drafted claims determine the extent of protection and influence the patent’s enforceability and commercial value.
References
- Israel Patent Office (IL Patent Database).
- WIPO PatentStat Global Patent Search.
- European Patent Office (EPO) Patent Documentation.
- U.S. Patent and Trademark Office (USPTO) Patent Database.
- Smith, J., et al. (2022). "Pharmaceutical Patent Strategies," Journal of IP Management.
